Painful purinergic receptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 324, Issue 2, 2008, Pages 409-415

  Donnelly Roberts, Diana ^a   McGaraughty, Steve ^a   Shieh, Char Chang ^a   Honore, Prisca ^a   Jarvis, Michael F ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 6 N METHYLADENOSINE 3',5' BISPHOSPHATE; 5 (3 BROMOPHENYL) 1,3 DIHYDRO 2H BENZOFURO[3,2 E] 1,4 DIAZEPIN 2 ONE; 5 [[(3 PHENOXYBENZYL)(1,2,3,4 TETRAHYDRO 1 NAPHTHYL)AMINO]CARBONYL]TRIMELLITIC ACID; A 438079; A 740003; ANTISENSE OLIGONUCLEOTIDE; IVERMECTIN; PURINERGIC P2X RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG;

ALLODYNIA; ARTICLE; CELL INTERACTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG STRUCTURE; GENETIC VARIABILITY; GLIA CELL; HUMAN; HYPERALGESIA; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; HUMANS; PAIN; PAIN MEASUREMENT; RECEPTORS, PURINERGIC; URIDINE TRIPHOSPHATE;

EID: 38749115790     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.105890     Document Type: Article

References (57)

1. Bleehen T and Keele CA (1977) Observation on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 3:367-377.
2. Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659-797.
3. Burnstock G and Williams M (2000) P2 purinergic receptors: modulation of cell function and therapeutic potential. J Pharmacol Exp 295:862-869.
4. 7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114:386-396.
5. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, and De Koninck Y (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017-21.
6. Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, and De Koninck Y (2003) Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature 424:938-42.
7. 7 antagonist, oxidized ATP, in arthritic rats. Neurosci Lett 327:87-90.
8. DiVirgilio F (2006) Purinergic signalling between axons and microglia, in Purinergic Signalling in Neuron-Glia Interactions. Vol. 276, pp. 253-262. Wiley, Chichester, UK.
9. 7 receptor function and indicates a role in chronic pain states. Br J Pharmacol 151:571-579.
10. 7 joins the society of heteromeric ATP-gated receptor channels. Mol Pharmacol 72:1402-1405.
11. 7 receptor: a key player in IL-1 processing and release. J Immunol 176:3877-3883.
12. 4 receptor antagonists for the treatment of arteriosclerosis and restenosis. DE 10312969A1. 1-14.
13. 4 receptor reveals pharmacological differences to the rat homologue. Mol Pharmacol 51:109-118.
14. Gerevich Z, Borvendeg SJ, Schroder W, Franke H, Wirkner K, Norenberg W, Furst S, Gillen C, and Illes P (2004) Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J Neurosci 24:797-807.
15. 3 receptor-channels in rat dorsal root ganglion neurons. Eur J Pharmacol 521:34-38.
16. Gerevich Z, Zadori Z, Muller C, Wirkner K, Schroder W, Rubini P, and Illes P (2007) Metabotropic P2Y receptors inhibit P2X(3) receptor-channels via G protein-dependent facilitation of their desensitization. Br J Pharmacol 151:226-236.
17. Gever JR, Cockayne DA, Dillon MP, Burnstock G, and Ford APDW (2006) Pharmacology of P2X channels. Eur J Physiol 452:513-537.
18. 7 heteromeric receptors. Mol Pharmacol 72:1447-1456.
19. Hamilton SG, Warburton J, Bhattacharjee A, Ward J, and McMahon SB (2000) ATP in human skin elicits a dose-related pain response under conditions of hyperalgesia. Brain 123:1238-1246.
20. Hilliges M, Weidner C, Schmelz M, Schmidt R, Orstavik K, Torebjork E, and Handwerker H (2002) ATP Responses in human C nociceptors. Pain 98:59-68.
21. Ho BT, Huo YY, Lu JG, Newman RA, and Levin VA (1992) Analgesic activity of anticancer agent suramin. Anti-Cancer Drugs 3:91-94.
22. Holton FA and Holton PJ (1954) The capillary dilator substances in dry powders of spinal roots; a possible role for adenosine triphosphate in chemical transmission from nerve endings. J Physiol 126:124-140.
23. Holton P (1959) The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves. J Physiol 145:494-504.
24. Honore P and Jarvis MF (2006) Acute and chronic pain, in Comprehensive Medicinal Chemistry II (Triggle DJ and Taylor JB eds) Vol. 6, pp. 327-349, Elsevier, Oxford.
25. Honore P, Wade CL, Zhong C, Harris RR, Wu C, Ghayur T, Iwakura Y, Decker MW, Faltynek C, Sullivan J, et al. (2006a) Interleukin-1αβ gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav Brain Res 167:355-364.
26. Honore P, Donnelly-Roberts D, Namovic M, Hsieh G, Zhu C, Mikusa J, Hernandez G, Zhong C, Gauvin D, Chandran P, et al. (2006b) A-740003 (N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl) -2-(3,4-dimethoxyphenyl) acetamide, a novel and selective P2X7 receptor antagonist dose-dependently reduces neuropathic pain in the rat. J Pharmacol Exp Ther 319:1376-1385.
27. Honore P, Mikusa J, Bianchi B, McDonald H, Cartmell J, Faltynek C, and Jarvis MF (2002) TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain 96: 99-105.
28. Inoue K (2006) The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 109:210-26.
29. Jacobson KA, Jarvis MF, and Williams M (2002) Purine and pyrimidine (P2) receptors as drug targets. J Med Chem 45:4057-4093.
30. Jahr CE and Jessell TM (1983) ATP excites a subpopulation of rat dorsal horn neurones. Nature 304:730-733.
31. Jarvis MF (2003) Contributions of P2X3 homomeric and heteromeric channels to acute and chronic pain. Expert Opin Ther Targets 7:513-522.
32. Jarvis MF, Burgard EC, McGaraughty S, Honore P, Lynch K, Brennan TJ, Subieta A, Van Biesen T, Cartmell J, Bianchi B, et al. (2002) A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Natl Acad Sci U S A 99: 17179-17184.
33. 3 allosteric modulator, Cibacron blue. Br J Pharmacol 132:259-269.
34. + release. Am J Physiol Cell Physiol 286:C1100-C1108.
35. Khakh BS and North RA (2006) P2X receptors as cell-surface ATP sensors in health and disease. Nature 442:527-532.
36. Kim C, Chung JM, and Chung K (2003) Changes in the gene expression of six subtypes of P2X receptors in rat dorsal root ganglion after spinal nerve ligation. Neurosci Lett 337:81-84.
37. 7 receptor alters leukocyte function and attenuates an inflammatory response. J Immunol 168: 6436-6445.
38. 2 receptor and TRPV channel by ATP: implications for ATP induced pain. Cell Mol Neurobiol 25:819-832.
39. MacKenzie A, Wilson HL, Kiss-Tosh E, Dower SK, North RA, and Surprenant A (2001) Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 8:825-835.
40. 7-related modulation of pathological nociception in rats. Neuroscience 146:1817-1828.
41. McGaraughty S and Jarvis MF (2006) Purinergic control of neuropathic pain. Drug Dev Res 67:376-388.
42. 2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration. Br J Pharmacol 140:1381-1388.
43. 2 metabotropic receptors in ATP-induced transient receptor potential vanilloid receptor 1-mediated thermal hypersensitivity. J Neurosci 23:6058-6062.
44. Nakagawa T, Wakamatsu K, Zhang N, Maeda S, Minami M, Satoh M, and Kaneko S (2007) Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience 147:445-455.
45. 7 antagonists. J Med Chem 49:3659-3666.
46. North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013-1067.
47. Okada M, Nakagawa T, Minami M, and Satoh M (2002) Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Ther 303:66-73.
48. Perl ER (2007) Ideas about pain, a historical view. Nat Rev Neurosci 8:71-80.
49. Perregaux DG and Gabel CA (1994) Interleukin-1β maturation and release in response to ATP and nigericin. J Biol Chem 269:15195-15203.
50. Sawynok J (2007) Adenosine and ATP receptors. Handb Exp Pharmacol 177:309-328 .
51. 7 receptors. J Biol Chem 276:125-132.
52. Stucky CL, Medler KA, and Molliver DC (2004) The P2Y agonist UTP activates cutaneous afferent fibers. Pain 109:36-44.
53. 7). Science 272:735-738.
54. 2 receptor. Biochem Biophys Res Commun 351:559-565.
55. Tominaga M, Wada M, and Masu M (2001) Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci U S A 98:6951-6956.
56. Wolf G, Yirmiya R, Goshen I, Iverfeldt K, Holmlund L, Takeda K, and Shavit Y (2004) Impairment of interleukin-1 (IL-1) signaling reduces basal pain sensitivity in mice: genetic, pharmacological and developmental aspects. Pain 104:471-480.
57. Xiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, Yang L, Huang WJ, Fu G, Xu SH, et al. (2002) Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A 99:8360-8365.